Home / Stocks / LBRX

LBRX insider trading

LB PHARMACEUTICALS INC — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
5
Bought · 24 mo
$85.0M
Buys · last 90 days
1 · $10.0M
Most recent buy
2026-08-03

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-08-03Deep Track Biotechnology Master Fund, Ltd.
10% owner
Bought286,205$34.94$10.0M
2025-09-16Deep Track Biotechnology Master Fund, Ltd.
10% owner
Bought2,666,666$15.00$40.0M
2025-09-16Pontifax Management 4 G.P. (2015) Ltd.
10% owner
Bought1,000,000$15.00$15.0M
2025-09-16Nussbaum Ran
Director
Bought1,000,000$15.00$15.0M
2025-09-16Belldegrun Arie
10% owner
Bought333,333$15.00$5.0M

Most active insider buyers

InsiderRoleBuysTotal bought
Deep Track Biotechnology Master Fund, Ltd.10% owner2$50.0M
Pontifax Management 4 G.P. (2015) Ltd.10% owner1$15.0M
Nussbaum RanDirector1$15.0M
Belldegrun Arie10% owner1$5.0M

See LBRX on the chart

Every insider buy and sell for LBRX plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.